...
首页> 外文期刊>Biochimica et biophysica acta: international journal of biochemistry and biophysics >Bradykinin modulates the ouabain-insensitive Na+-ATPase activity from basolateral membrane of the proximal tubule.
【24h】

Bradykinin modulates the ouabain-insensitive Na+-ATPase activity from basolateral membrane of the proximal tubule.

机译:缓激肽调节近端小管基底外侧膜对哇巴因不敏感的Na + -ATPase活性。

获取原文
获取原文并翻译 | 示例

摘要

This paper studies the modulation by bradykinin of the ouabain-insensitive Na+-ATPase activity in both renal cortex homogenate and basolateral membrane from proximal tubule. The increase in bradykinin concentration from 10-14 to 10-10 M stimulated the ouabain-insensitive Na+-ATPase activity in cortex homogenates about 2.2-fold, but inhibited the enzyme activity of basolateral membrane preparations by 60%. In both preparations, the maximal effect was obtained with 10-10 M bradykinin. Further increase in the concentration of bradykinin completely abolished these effects. The antagonist of the B2 receptor, Hyp3, completely abolished the effect of 10-10 M bradykinin on the Na+-ATPase activity in the basolateral membrane preparation in a dose-dependent manner, but had no effect on the bradykinin stimulated enzyme activity of the cortex homogenate. Furthermore, in the presence of 10-7 M Hyp3, 10-10 M bradykinin stimulated the Na+-ATPase activity by 45% in the basolateral membrane preparations. The increase in des-Arg9-bradykinin concentration from 10-12 to 10-7 M, an agonist of the B1 receptor, stimulated the Na+-ATPase activity of the cortex homogenates and of the basolateral membrane preparations by 105 and 148%, respectively. In the presence of 25 microM mergetpa, an inhibitor of kininase I, the increase in bradykinin concentration from 10-12 to 10-10 M promoted similar inhibition of the Na+-ATPase activity of both cortex homogenates and basolateral membrane preparations. These results suggest that bradykinin stimulated the Na+-ATPase activity of proximal tubule through the interaction with B1 receptors and inhibited the enzyme through the interaction with B2 receptors. Furthermore, the cortex homogenate expresses a kininase I activity that cleaves bradykinin to des-Arg9-bradykinin.
机译:本文研究了缓激肽对近端肾小管肾皮质匀浆和基底外侧膜中哇巴因不敏感的Na + -ATPase活性的调节作用。缓激肽浓度从10-14 M增加到10-10 M刺激皮质匀浆中对哇巴因不敏感的Na + -ATPase活性约2.2倍,但抑制了基底外侧膜制剂的酶活性60%。在这两种制剂中,使用10-10 M缓激肽都能获得最大的效果。缓激肽浓度的进一步提高完全消除了这些作用。 B2受体的Hyp3拮抗剂以剂量依赖的方式完全消除了10-10 M缓激肽对基底外侧膜制剂中Na + -ATPase活性的影响,但对皮质的缓激肽刺激的酶活性没有影响匀浆。此外,在10-7 M Hyp3的存在下,基底外侧膜制剂中10-10 M缓激肽刺激Na + -ATPase活性达45%。作为B1受体激动剂的des-Arg9-缓激肽浓度从10-12 M增加到10-7 M,分别刺激皮质匀浆和基底外侧膜制剂的Na + -ATPase活性分别为105和148%。在25 microM mergetpa(一种激肽酶I抑制剂)的存在下,缓激肽浓度从10-12 M增加到10促进了皮质匀浆和基底外侧膜制剂对Na + -ATPase活性的类似抑制。这些结果表明缓激肽通过与B1受体的相互作用刺激近端小管的Na + -ATPase活性,并通过与B2受体的相互作用抑制酶。此外,皮质匀浆表达激肽酶I活性,该活性将缓激肽裂解为des-Arg9-缓激肽。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号